Jacobs Levy Equity Management, Inc Zynerba Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $911,466 - $1.31 Million	-245,018 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.98 $500,117 - $780,862	130,579 Added 114.1%	245,018 $1.3 Million
Q4 2020 Feb 16, 2021	BUY	$3.27 - $4.64 $374,215 - $530,996	114,439 New	114,439 $378,000
Q2 2018 Aug 14, 2018	SELL	$7.98 - $12.39 $98,952 - $153,636	-12,400 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.49 - $13.46 $105,276 - $166,904	12,400 New	12,400 $108,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.